Occudo Quantitative Strategies LP Kura Oncology, Inc. Transaction History

Occudo Quantitative Strategies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$11.78 - $16.98 $354,507 - $510,996	-30,094 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$12.22 - $19.57 $420,954 - $674,147	-34,448 Reduced 53.37%	30,094 $421,000
Q3 2021 Nov 15, 2021	BUY	$15.42 - $21.72 $767,268 - $1.08 Million	49,758 Added 336.57%	64,542 $1.21 Million
Q2 2021 Aug 16, 2021	SELL	$20.85 - $29.88 $16,680 - $23,904	-800 Reduced 5.13%	14,784 $308,000
Q1 2021 May 14, 2021	SELL	$24.75 - $39.14 $240,669 - $380,597	-9,724 Reduced 38.42%	15,584 $441,000
Q4 2020 Feb 16, 2021	BUY	$29.0 - $41.62 $733,932 - $1.05 Million	25,308 New	25,308 $827,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $603M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.